OPK Q4 2021 Earnings — OPKO Health, Inc. Revenue & Financial Results | Market Cap Arena

OPKOPKO Health, Inc.

$933M

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$401M-18.9% YoY

Gross Profit

$109M27.0% margin

Operating Income

-$63M-15.7% margin

Net Income

-$74M-18.4% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

+4.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$12M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$2.4B

Total Liabilities

$715M

Stockholders' Equity

$1.7B

Cash & Equivalents

$135M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$401M	$495M	-18.9%
Gross Profit	$109M	$176M	-38.3%
Operating Income	-$63M	$49M	-228.0%
Net Income	-$74M	$32M	-328.4%

Revenue Segments

Service

$278M88%

Product

$35M11%

Transfer of Intellectual Property and Other

$3M1%

Geographic Segments

UNITED STATES

$371M92%

CHILE

$15M4%

IRELAND

$8M2%

SPAIN

$6M1%

MEXICO

$2M1%

Other Countries

$65,0000%

ISRAEL

$20,0000%